Samy Y. Elkhawaga 个人学术档案

引用次数

	总计	2019 年至今
引用	721	721
h 指数	14	14
i10 指数	17	17

600

300

150

450

2022202320248 581 131

合著作者

Hesham A. El-MahdyLecturer of Clinical Biochemistry and Molecular Biology (Ph.D.), Faculty of Pharmacy, Al-Azhar Univ.在 azhar.edu.eg 的电子邮件经过验证
Ahmed Soliman DoghishBadr University in Cairo在 azhar.edu.eg 的电子邮件经过验证
Elsayed G. E. ElsakkaLecturer of Biochemistry and Molecular Biology, faculty of Pharmacy, Alazhar university, Cairo在 azhar.edu.eg 的电子邮件经过验证
Ahmed Ibrahim AbulsoudProfessor of Biochemistry, Faculty of Pharmacy, Al-Azhar University and Heliopolis University在 azhar.edu.eg 的电子邮件经过验证
Nourhan Mohamed AbdelmaksoudHeliopolis University在 hu.edu.eg 的电子邮件经过验证
Mahmoud Mohamed MokhtarLecturer of Biochemistry and Molecular Biology在 azhar.edu.eg 的电子邮件经过验证
Maghawry HegazyLecturer of Clinical Biochemistry and Molecular Biology, Faculty of Pharmacy Al-Azhar University在 azhar.edu.eg 的电子邮件经过验证
Ahmed A. El-HusseinyFaculty of Pharmacy, Al-Azhar University and Egyptian Russian University在 azhar.edu.eg 的电子邮件经过验证
El-Husseiny, Hussein M.Tokyo University of Agriculture and Technology,Japan; Faculty of Vet. Med., Benha University在 fvtm.bu.edu.eg 的电子邮件经过验证
Ahmed Elshafei, Ph.D.Professor Associate of Medical Biochemistry, Nutrition and Molecular Biology, Al-Azhar University在 azhar.edu.eg 的电子邮件经过验证
Sherif S. Abdel MageedAssistant Lecturer-Pharmacology-BUC在 buc.edu.eg 的电子邮件经过验证
Mohammed Salah ElballalFaculty of Pharmacy, Badr University in Cairo在 buc.edu.eg 的电子邮件经过验证
Dr. Osama A. MohammedAssociate Professor of Clinical Pharmacology, College of Medicine, University of Bisha, Saudi Arabia在 ub.edu.sa 的电子邮件经过验证
Walaa Ahmed El-DakrouryDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Badr University in在 buc.edu.eg 的电子邮件经过验证
Eman A. MadyTokyo University of Agriculture and Technology,Japan; Faculty of Vet. Med., Benha University在 fvtm.bu.edu.eg 的电子邮件经过验证
Emad Gamil khidrAssociate Professor of Biochemistry and Molecular Biology, Al-Azhar University在 azhar.edu.eg 的电子邮件经过验证
Reem K.ShahinBadr University in Cairo在 buc.edu.eg 的电子邮件经过验证
Doaa Fathi OmarBiochemistry department Faculty of Pharmacy Heliopolis University在 hu.edu.eg 的电子邮件经过验证
Omnia SarhanLecturer of pharmaceutics在 buc.edu.eg 的电子邮件经过验证
Aya A.El-DemerdashAssistant lecturer of pharmacology, Badr university in cairo在 buc.edu.eg 的电子邮件经过验证

关注

Samy Y. Elkhawaga

Lecturer of Biochemistry and Molecular Biology, Faculty of Pharmacy, Al-Azhar University

在 azhar.edu.eg 的电子邮件经过验证

Cancer Biology Gene Polymorphism MicroRNAs Autoimmune disorders


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions AI Abulsoud, HM El-Husseiny, AA El-Husseiny, HA El-Mahdy, A Ismail, ... Biomedicine & Pharmacotherapy 157, 113977, 2023	80	2023
miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers AS Doghish, A Ismail, HA El-Mahdy, SY Elkhawaga, EGE Elsakka, ... Life Sciences 314, 121321, 2023	67	2023
miRNAs as cornerstones in adipogenesis and obesity SY Elkhawaga, A Ismail, EGE Elsakka, AS Doghish, MA Elkady, ... Life Sciences 315, 121382, 2023	62	2023
miRNAs inspirations in hepatocellular carcinoma: detrimental and favorable aspects of key performers HA El-Mahdy, AAM Sallam, A Ismail, SY Elkhawaga, MA Elrebehy, ... Pathology-Research and practice 233, 153886, 2022	59	2022
The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance–a focus on signaling pathways interplay A Ismail, AI Abulsoud, D Fathi, A Elshafei, HA El-Mahdy, EGE Elsakka, ... Pathology-Research and Practice 240, 154222, 2022	54	2022
Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways AS Doghish, HA El-Mahdy, A Ismail, M Hegazy, MM Mokhtar, ... Pathology-Research and Practice 243, 154371, 2023	53	2023
miRNAs as potential game-changers in melanoma: a comprehensive review GM Abd-Allah, A Ismail, HA El-Mahdy, EGE Elsakka, AA El-Husseiny, ... Pathology-Research and Practice 244, 154424, 2023	49	2023
Impact of the mother's gut microbiota on infant microbiome and brain development EA Mady, AS Doghish, WA El-Dakroury, SY Elkhawaga, A Ismail, ... Neuroscience & Biobehavioral Reviews 150, 105195, 2023	45	2023
A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance AS Doghish, M Hegazy, A Ismail, HA El-Mahdy, EGE Elsakka, ... Pathology-Research and Practice 245, 154442, 2023	42	2023
The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance–A focus on signaling pathways interplay M Hegazy, MA Elkady, AM Yehia, EGE Elsakka, AI Abulsoud, ... Pathology-Research and Practice 246, 154510, 2023	39	2023
The potential role of miRNAs in the pathogenesis of cardiovascular diseases–A focus on signaling pathways interplay EG Khidr, AI Abulsoud, AA Doghish, HA El-Mahdy, A Ismail, MS Elballal, ... Pathology-Research and Practice 248, 154624, 2023	34	2023
miRNAs orchestration of cardiovascular diseases–Particular emphasis on diagnosis, and progression EGE Elsakka, AI Abulsoud, HA El-Mahdy, A Ismail, MS Elballal, ... Pathology-Research and Practice 248, 154613, 2023	29	2023
Decoding the role of miRNAs in multiple myeloma pathogenesis: a focus on signaling pathways AM Yehia, EGE Elsakka, AI Abulsoud, NM Abdelmaksoud, A Elshafei, ... Pathology-Research and Practice, 154715, 2023	29	2023
miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma MA Elkady, AM Yehia, EGE Elsakka, AI Abulsoud, NM Abdelmaksoud, ... Pathology-Research and Practice, 154704, 2023	27	2023
From diagnosis to resistance: a symphony of miRNAs in pheochromocytoma progression and treatment response EGE Elsakka, A Elshafei, MA Elkady, AM Yehia, AI Abulsoud, RK Shahin, ... Naunyn-Schmiedeberg's Archives of Pharmacology 397 (4), 1957-1969, 2024	13	2024
Possible role of miRNAs in pheochromocytoma pathology-Signaling pathways interaction SY Elkhawaga, A Elshafei, MA Elkady, AM Yehia, AI Abulsoud, ... Pathology-Research and Practice, 154856, 2023	12	2023
NFKB1 promoter–94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels … SY Elkhawaga, MH Gomaa, MM Elsayed, AA Ebeed Clinical Rheumatology 40, 2927-2937, 2021	10	2021
In vitro and in silico evaluation of new thieno [2, 3-d] pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2 SA El-Metwally, AA Abuelkhir, H Elkady, MS Taghour, IM Ibrahim, ... Computational Biology and Chemistry 106, 107928, 2023	7	2023
Discovery of new uracil and thiouracil derivatives as potential HDAC inhibitors OR Elbatrawy, M Hagras, MA El Deeb, F Agili, M Hegazy, AA El-Husseiny, ... Pharmaceuticals 16 (7), 966, 2023	5	2023
Design and synthesis of novel pyrazolopyrimidine candidates as promising EGFR-T790M inhibitors and apoptosis inducers AA Gaber, M Sharaky, AA Elmaaty, MM Hammouda, AAE Mourad, ... Future Medicinal Chemistry 15 (19), 1773-1790, 2023	2	2023

系统目前无法执行此操作，请稍后再试。

文章 1–20

每年引用数

重复的引用

合并的引用

添加合著者合著作者

上传 PDF

关注此作者

引用次数

合著作者

引用